Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Bergh

Showing results (1-10 of 186) with videos related to

Pageof 19
Sort By:
Acta Paediatrica (Oslo, Norway : 1992)|April 28, 2007
Studies of cryptorchidism in experimental animal modelsAnders Bergh, Olle Söder
Cancers|November 12, 2013
The stroma-a key regulator in prostate function and malignancyChristina Hägglöf, Anders Bergh
The Journal of Endocrinology|January 9, 2008
Testosterone-stimulated growth of the rat prostate may be driven by tissue hypoxia and hypoxia-inducible factor-1alphaStina Häggström Rudolfsson, Anders Bergh
Expert Opinion on Therapeutic Targets|February 25, 2009
Hypoxia drives prostate tumour progression and impairs the effectiveness of therapy, but can also promote cell death and serve as a therapeutic targetStina Häggström Rudolfsson, Anders Bergh
The Prostate|September 25, 2004
Characterization of the autochthonous transgenic adenocarcinoma of the mouse prostate (TRAMP) as a model to study effects of castration therapyPernilla Wikström, Charlotta Lindahl, Anders Bergh
Endocrine Connections|October 15, 2017
Clinical relevance of androgen receptor alterations in prostate cancerEmma Jernberg, Anders Bergh, Pernilla Wikström
Plos One|January 5, 2011
Tumour Cannabinoid CB(1) receptor and phosphorylated epidermal growth factor receptor expression are additive prognostic markers for prostate cancerChristopher J Fowler, Peter Hammarsten, Anders Bergh
The Prostate|August 3, 2004
Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epitheliumWanzhong Wang, Anders Bergh, Jan-Erik Damber
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 28, 2009
Increased p53 immunoreactivity in proliferative inflammatory atrophy of prostate is related to focal acute inflammationWanzhong Wang, Anders Bergh, Jan-Erik Damber
Acta Crystallographica. Section C, Crystal Structure Communications|May 8, 2004
Methyl 2,6-di-O-benzyl-3,4-O-phenylphosphinediyl-beta-D-galactopyranoside(P-B)borane with chirality on the P atomMagnus J Johansson, Anders Bergh, Krister Larsson
Pageof 19

Showing results (1-10 of 186) with videos related to

Sort By:
Pageof 19
Acta Paediatrica (Oslo, Norway : 1992)|April 28, 2007
Studies of cryptorchidism in experimental animal modelsAnders Bergh, Olle Söder
Cancers|November 12, 2013
The stroma-a key regulator in prostate function and malignancyChristina Hägglöf, Anders Bergh
The Journal of Endocrinology|January 9, 2008
Testosterone-stimulated growth of the rat prostate may be driven by tissue hypoxia and hypoxia-inducible factor-1alphaStina Häggström Rudolfsson, Anders Bergh
Expert Opinion on Therapeutic Targets|February 25, 2009
Hypoxia drives prostate tumour progression and impairs the effectiveness of therapy, but can also promote cell death and serve as a therapeutic targetStina Häggström Rudolfsson, Anders Bergh
The Prostate|September 25, 2004
Characterization of the autochthonous transgenic adenocarcinoma of the mouse prostate (TRAMP) as a model to study effects of castration therapyPernilla Wikström, Charlotta Lindahl, Anders Bergh
Endocrine Connections|October 15, 2017
Clinical relevance of androgen receptor alterations in prostate cancerEmma Jernberg, Anders Bergh, Pernilla Wikström
Plos One|January 5, 2011
Tumour Cannabinoid CB(1) receptor and phosphorylated epidermal growth factor receptor expression are additive prognostic markers for prostate cancerChristopher J Fowler, Peter Hammarsten, Anders Bergh
The Prostate|August 3, 2004
Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epitheliumWanzhong Wang, Anders Bergh, Jan-Erik Damber
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 28, 2009
Increased p53 immunoreactivity in proliferative inflammatory atrophy of prostate is related to focal acute inflammationWanzhong Wang, Anders Bergh, Jan-Erik Damber
Acta Crystallographica. Section C, Crystal Structure Communications|May 8, 2004
Methyl 2,6-di-O-benzyl-3,4-O-phenylphosphinediyl-beta-D-galactopyranoside(P-B)borane with chirality on the P atomMagnus J Johansson, Anders Bergh, Krister Larsson
Pageof 19